Heron Therapeutics Inc

NASDAQ:HRTX   12:51:45 PM EDT
17.60
+0.45 (+2.62%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.61B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$26 Million
Adjusted EPS-$0.54
See more estimates
10-Day MA$17.15
50-Day MA$17.20
200-Day MA$16.94
See more pivots

Heron Therapeutics Inc Stock, NASDAQ:HRTX

4242 Campus Point Court, Suite 200, San Diego, California 92121
United States of America
Phone: +1.858.251.4400
Number of Employees: 223

Description

Heron Therapeutics, Inc. is a biotechnology company, which engages in the development of pharmaceutical products for patients suffering from cancer. Its products portfolio include SUSTOL, Cinvanti, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.